The drug blocks the activity of a protein known as mammalian target of rapamycin (mTOR), which promotes proliferation through the activation of proteins such as S6 kinase. Although the mTOR ...

QTORIN™ rapamycin is a topical gel designed to target the underlying drivers of cutaneous VMs by inhibiting the mTOR pathway. Unlike the off-label systemic mTOR inhibitors used in some cases ...